CARCINOMA, RENAL CELL
Clinical trials for CARCINOMA, RENAL CELL explained in plain language.
Never miss a new study
Get alerted when new CARCINOMA, RENAL CELL trials appear
Sign up with your email to follow new studies for CARCINOMA, RENAL CELL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo trial aims to fight advanced cancers
Disease control Recruiting nowThis study tests a new drug called BMS-986340, alone or with other cancer treatments, in people with advanced solid tumors like lung, colon, or breast cancer. The goal is to find safe doses and check for side effects. About 1,100 adults with tumors that have worsened after standa…
Matched conditions: CARCINOMA, RENAL CELL
Phase: PHASE1, PHASE2 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New pill combo aims to fight advanced kidney cancer
Disease control Recruiting nowThis Phase 3 trial is testing whether adding the drug zanzalintinib to belzutifan helps people with advanced kidney cancer live longer and keep the cancer from growing. About 758 participants who have already tried standard treatments will receive either the combination or belzut…
Matched conditions: CARCINOMA, RENAL CELL
Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
Belzutifan extension trial aims to extend lives in VHL and advanced cancer
Disease control Recruiting nowThis extension study follows people with von Hippel-Lindau (VHL) disease or advanced solid tumors who are already taking belzutifan in another trial. The goal is to see how long they live and how safe the drug is over the long term. About 450 participants will take belzutifan by …
Matched conditions: CARCINOMA, RENAL CELL
Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New hope for advanced kidney cancer: experimental drug enters human trials
Disease control Recruiting nowThis study tests a new medicine, PF-08634404, in adults with advanced kidney cancer that has spread. The goal is to see if the drug is safe and can shrink tumors when used alone or with other cancer drugs. About 224 participants who have not had prior treatment for their advanced…
Matched conditions: CARCINOMA, RENAL CELL
Phase: PHASE1, PHASE2 • Sponsor: Pfizer • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Mushroom compound targets kidney cancer in dialysis patients
Disease control Recruiting nowThis early-stage trial is testing a drug called orellanine, derived from a mushroom, in 75 people with advanced kidney cancer who are also on dialysis. The drug is given intravenously to see if it is safe and can shrink tumors. All participants have end-stage kidney disease and h…
Matched conditions: CARCINOMA, RENAL CELL
Phase: PHASE1, PHASE2 • Sponsor: Oncorena AB • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Could a prostate cancer drug help fight kidney cancer?
Disease control Recruiting nowThis study tests whether adding bicalutamide (a prostate cancer drug) to sunitinib (a standard kidney cancer drug) can help people whose kidney cancer has stopped responding to other targeted therapies. The trial will enroll 28 adults with advanced renal cell carcinoma. Researche…
Matched conditions: CARCINOMA, RENAL CELL
Phase: PHASE1, PHASE2 • Sponsor: State University of New York at Buffalo • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
New hope for kidney cancer: Real-World study tests vorolanib as Second-Line therapy
Disease control Recruiting nowThis study looks at how well the drug vorolanib works for people with advanced kidney cancer that cannot be removed by surgery or has spread. It is for patients who need a second treatment after their first one stopped working. The study will track how long the cancer stays under…
Matched conditions: CARCINOMA, RENAL CELL
Sponsor: Jinling Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
AI could help surgeons spot aggressive kidney tumors before operating
Diagnosis Recruiting nowThis study is testing whether a computer program (deep learning) can accurately tell the difference between early-stage (T1-T2) and more advanced (T3) kidney cancer on CT scans. Researchers will train the AI on 1,000 patients' scans and check its accuracy. If it works, the tool c…
Matched conditions: CARCINOMA, RENAL CELL
Sponsor: Peking University First Hospital • Aim: Diagnosis
Last updated Jun 26, 2026 15:34 UTC